the sensor cartridge (Fig.1b and c). For glycolysis assay, glucose,
oligomycin, and 2-deoxy-D-glucose (2DG) will be sequentially
injected, while for mitochondrial respiration assay, oligomycin,
carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP),
and rotenone/antimycin A (Rot/AA) will be serially injected.
In order to obtain the desired final concentration for each
reagent to be injected, appropriate intermediate solution of each
reagent needs to be calculated. This will depend on the volume of
the reagent injected and the final volume of the medium once the
injection has occurred. In the present protocol, the starting volume
of medium in each well is 500μl, while every injection is of 80μl.
In this way, following the A to D injection sequence, dilution of
each injected reagent will be calculated according to Table1. The
present protocol is based on the use of three of the four injection
ports. The remaining port allows the injection of an additional
reagent or drug during the Seahorse XFe assay, further increasing
the possibilities of metabolic tests and strategies that can be
performed.
Reagent Stock Solutions
- Glucose solution: 20% (w/v) glucose. Prepare a sterile solution
by dissolving 20 g ofD-glucose in 100 ml of ultrapure water,
filter (0.22μm), and store at 4C. - Oligomycin: 10 mM oligomycin A in DMSO (seeNote 3).
- FCCP: 2.5 mM FCCP in DMSO. Keep protected from light
(seeNote 3). - Rot: 2.5 mM rotenone (Rot) in DMSO (seeNote 3).
- AA: 2.5 mM antimycin A (AA) in DMSO (seeNote 3).
Reagent Intermediate Solutions for Glycolysis Assay
To run a glycolysis assay, intermediate solutions of glucose,
oligomycin and 2DG are calculated and indicated in Table2.
Prepare the following intermediate solution of each reagent in
pre-warmed MGA medium:
Table 1
Calculation of the dilution factors for the reagents to be loaded in the cartridge injection ports
Injection port
sequence
Volume (μl) for
each injection
Volume (μl) of medium
after the injection
Dilution factor of each
reagent to be loaded
A 80 580 7.25
B 80 660 8.25
C 80 740 9.25
D 80 820 10.25
292 Claudia Marinangeli et al.